期刊文献+

腺苷预处理对非体外循环冠状动脉旁路移植术患者心肌TNF-α mRNA和ICAM-1 mRNA表达的影响 被引量:3

Effects of adenosine preconditioning on expression of myocardial TNF-α mRNA and ICAM-1 mRNA in patients undergoing off-pump coronary artery bypass graft operation
原文传递
导出
摘要 目的 探讨腺苷预处理对非体外循环冠状动脉旁路移植术(OPCABG)患者心肌肿瘤坏死因子-α(TNF-α)mRNA和细胞间黏附分子-1(ICAM-1)mRNA表达的影响。方法 择期初次行OPCABG患者40例,年龄44~68岁,随机分为2组(n=20):对照组和腺苷组。腺苷组于冠状动脉吻合前15min经颈内静脉输注腺苷50μg·kg^-1·min^-1,1min后上调至100μg·kg^-1·min^-1,2min后上调至150μg·kg^-1·min^-1,输注7min。输注结束后5min开始冠状动脉吻合,对照组给予生理盐水。连续监测血液动力学参数。于腺苷预处理前(基础状态)和恢复血流15min时,取右心耳组织约0.5g,RT-PCR相对定量法测定心肌TNF—α mRNA和ICAM-1mRNA的表达,透射电镜观察心肌超微结构。结果与对照组比较,腺苷组心肌TNF—αmRNA和ICAM—lmRNA表达下调(P〈0.05),心肌病理损伤减轻。结论腺苷预处理可通过下调OPCABG患者心肌TNF—α和ICAM—1mRNA表达,从而减轻心肌损伤。 [Abstract] Objective To investigate the effects of adenosine preconditioning on the expression of myocardial TNF-α mRNA and ICAM-1 mRNA in patients undergoing off-pump coronary artery bypass graft (OPCABG) .Methods Forty patients, aged 44-68 yr, with more than three coronary artery obstructions and ejection fraction≥ 40%, undergoing elective OPCABG, were randomly divided into 2 groups (n = 20 each): control group and ADO group. ADO group received adenosine preconditioning, the initial infusion rate was 50·μg· kg^-1·min^-1 , then increased to 100 μg·kg^-1·min^-1 after 1 min, increased to 150μg·kg^-1 ·min^-1 after 2 min and maintaining for 7 min. The vascular anastomosis was started at 5 min after preconditioning. While the control group received normal saline.instead of adenosine. Tissue samples of the right auricle were taken before preconditioning (baseline) and at 15 min after blood current return to measure the expression of myocardial TNF-α mRNA and ICAM-1 mRNA and the myocardial ultrastructure was observed. Hemodynamic parameters were monitored. Results The myocardial damage was milder in ADO group than in control group . The expression of myocardial TNF-α mRNA and ICAM-1 mRNA was significantly lower in ADO group than in control group ( P 〈 0.05). Conclusion Adenosine preconditioning can attenuate myocardium ischemia-reperfusion injury in patients undergoing OPCABG through down-regulating the expression of myocardial TNF-α mRNA and ICAM-1 mRNA.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2008年第4期342-345,共4页 Chinese Journal of Anesthesiology
关键词 腺苷 肿瘤坏死因子α 细胞粘附分子 冠状动脉旁路移植术 非体外循环 缺血预处理 Adenosine Tumor necrosis factor-alpha Cell adhesion molecules Coronary artery bypass, off-pump Ischemic preconditioning
  • 相关文献

参考文献18

  • 1Bufkin BL, Shearer ST, Vinten-Johansen J, et al. Preconditioning during simulated MIDCABG attenuates blood flow defects and nentrophil accumulation. Ann Thorac Surg, 1998,66:726-731.
  • 2Yao Z, Gross GJ. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels. Circulation, 1994, 89:1229-1236.
  • 3Toombs CF, McGee S, Johnston WE, et al. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation, 1992, 86 : 986-994.
  • 4高岚,张京范,于德水,王胜洵.腺苷对离体心脏再灌注后炎性因子TNF-α mRNA、ICAM-1 mRNA表达的影响[J].中华麻醉学杂志,2001,21(5):305-305. 被引量:9
  • 5Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-△△CT Method. Methods, 2001, 25 : 402-408.
  • 6Lee HL, LaFaro RL, Reed GE. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg, 1995, 10: 665-676.
  • 7Onimaru S, Nakamura K, Kariyazono H, et al. Inhibitory effects of edaravone on the production of tumor necrosis factor-alpha in the isolated heart undergoing isehemia and reperfusion. Heart Vessels, 2006, 21: 108-115.
  • 8Bozkurt B, Torre-Amione G, Warren MS, et al. Results of targeted anti- tumor necrosis factor therapy with etanercept(ENBREL) in patients with advanced heart failure. Circulation, 2001, 103: 1044-1047.
  • 9Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med, 1998, 25 : 404-433.
  • 10Vermeiren GL, Claeys MJ, Van Bockstaele D, et al. Reperfusion injury after focal myocardial ischemia: polymophonuclear leukocyte activation and its clinical implications. Resuscitation, 2000, 45: 35-61.

二级参考文献7

  • 1Meldrum D R,Immunology,1997年,92卷,472页
  • 2Gurevitch J,J Am Coll Cardiol,1996年,28卷,247页
  • 3Cain BS, Harken AH, Meldrum DR . Therapeutic strategies to reduce TNF-α mediated cardiac contractile depression following ischemia and reperfusion. J Mol Cell Cardiol , 1999,31: 931-947.
  • 4Cain BS, Meldrum DR,Dinarello CA, et al. Adenosine reduces cardiac TNF-α production and human myoCardial injury following ischemia-reperfusion. J Surg Res ,1998,76:117-123.
  • 5Stangl V, Baumann G, Stangl K, et al . Negative inotropic mediators released from the heart after myoCardial ischaemia-reperfusion. Cardiovasc Res, 2002,53:12-30.
  • 6Baldwin AS Jr. The NF-κB and IκB proteins:new discoveries and insights. Annu Rev Immunol, 1996, 14: 649-683.
  • 7李立志,张良清,邵义明,彭雪,刘新,杨健.腺苷预处理对缺血再灌注心肌损伤的保护及炎性细胞因子的影响[J].临床麻醉学杂志,2002,18(1):12-14. 被引量:5

共引文献9

同被引文献51

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部